MED13L 致病性误解变体 破坏蛋白质稳定性和相互作用,导致不同的临床结果
Thomas Smol1, Frédéric Frenois1, Morgane Billotte1
1Univ. Lille, CHU Lille, ULR7364 - RADEME - Maladies Rares du Développement Embryonnaire, F-59000 Lille, France.
HGG advances
|June 12, 2025
概括
在MED13L中的致病性误解变异破坏了蛋白质的稳定性和相互作用,导致各种智力障碍和发育迟缓. 这些发现揭示了MED13L相关疾病背后的多种分子机制.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 神经发育障碍 神经发育障碍
背景情况:
- MED13L基因变异与智力障碍,发育迟缓和明显的面部特征有关.
- 胡说八道和框架转移变体通常会导致具有已知的表型的哈普洛缺陷.
- 误解变体具有更广泛的临床严重程度,包括和运动延迟.
研究的目的:
- 研究五种致病性MED13L误解变异对蛋白质功能和临床表现的影响.
- 阐明在MED13L相关疾病中表型变异的基础上的分子机制.
主要方法:
- 分析了五种特定的MED13L误解变种 (p.Pro866Leu,p.Pro869Ser,p.Cys1131Tyr,p.Gly1899Arg,p.Thr2162Met).这些变种中的一个是MED13L.
- 评估蛋白质稳定性和细胞局部化.
- 利用3D蛋白质建模来预测与CDK8激酶模块的相互作用.
主要成果:
- 所有调查的误解变体都显示蛋白质稳定性降低.
- 一些变体表现出异常的细胞质局部化,表明结构和功能中断.
- 异构15变异与严重的表型 (,运动障碍) 相相关,而其他变异则表现出较轻微的效应.
- 3D建模表明与CDK8激酶模块的相互作用受损.
结论:
- 错误的MED13L变异通过包括蛋白质不稳定性和改变的分子相互作用在内的机制,有助于临床变异.
- 了解这些独特的致病途径对于诊断和管理MED13L相关疾病至关重要.
相关概念视频
Mutations
81.0K
Overview
81.0K
Translation
14.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.7K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Signal Sequences and Sorting Receptors
5.3K
Signal sequences are short amino acid sequences that guide newly synthesized proteins to their proper location within the cell. Classical signal sequences are fifteen to sixty amino acids long and present at the N-terminus of a polypeptide chain. Each signal sequence has a conserved segment of basic residues towards their N terminus, a hydrophobic core, and a C-terminus rich in polar residues. The C-terminus also contains a signal cleavage site and features a -3 -1 sequence motif. The -3-1...
5.3K


